Kaustav Das Gupta

Kaustav Das Gupta

Auto-generated profile, based on publicly available information

Kaustav Das Gupta

Australian Infectious Diseases Research Centre, The University of Queensland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2016 in Clinical & Translational Immunology
Verified
Journal Article
Open access
PDF file
KGKaustav Das Gupta
Kaustav Das Gupta
MSMelanie R Shakespear
Melanie R Shakespear
AIAbishek Iyer
Abishek Iyer
DFDavid P Fairlie
David P Fairlie
MSMatthew J Sweet
Matthew J Sweet
Macrophages have central roles in danger detection, inflammation and host defense, and consequently, these cells are intimately linked to most disease processes. Major advances in our understanding of the development and function of macrophages have recently come to light. For example, it is now clear that tissue‐resident macrophages can be derived from either blood monocytes or through local proliferation of phagocytes that are originally seeded during embryonic development. Metabolic state has also emerged as a major control point for macrophage activation phenotypes. Herein, we review recent literature linking the histone deacetylase (HDAC) family of enzymes to macrophage development and activation, particularly in relation to these recent developments. There has been considerable interest in potential therapeutic applications for small molecule inhibitors of HDACs (HDACi), not only for cancer, but also for inflammatory and infectious diseases. However, the enormous range of molecular and cellular processes that are controlled by different HDAC enzymes presents a potential stumbling block to clinical development. We therefore present examples of how classical HDACs control macrophage functions, roles of specific HDACs in these processes and approaches for selective targeting of drugs, such as HDACi, to macrophages. Development of selective inhibitors of macrophage‐expressed HDACs and/or selective delivery of pan HDACi to macrophages may provide avenues for enhancing efficacy of HDACi in therapeutic applications, while limiting unwanted side effects.

1 February 2020 in Cell Reports
Verified
Journal Article
Open access
KGKaustav Das Gupta
Kaustav Das Gupta
MSMelanie R. Shakespear
Melanie R. Shakespear
JCJames E.B. Curson
James E.B. Curson
AMAmbika Murthy
Ambika Murthy
AIAbishek Iyer
Abishek Iyer
MSMatthew J Sweet
Matthew J Sweet
Histone deacetylases (HDACs) drive innate immune cell-mediated inflammation. Here we identify class IIa HDACs as key molecular links between Toll-like receptor (TLR)-inducible aerobic glycolysis and macrophage inflammatory responses. A proteomic screen identified the glycolytic enzyme pyruvate kinase M isoform 2 (Pkm2) as a partner of proinflammatory Hdac7 in murine macrophages. Myeloid-specific Hdac7 overexpression in transgenic mice amplifies lipopolysaccharide (LPS)-inducible lactate and promotes a glycolysis-associated inflammatory signature. Conversely, pharmacological or genetic targeting of Hdac7 and other class IIa HDACs attenuates LPS-inducible glycolysis and accompanying inflammatory responses in macrophages. We show that an Hdac7-Pkm2 complex acts as an immunometabolism signaling hub, whereby Pkm2 deacetylation at lysine 433 licenses its proinflammatory functions. Disrupting this complex suppresses inflammatory responses in vitro and in vivo. Class IIa HDACs are thus pivotal intermediates connecting TLR-inducible glycolysis to inflammation via Pkm2.

11 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
XSXuan Sun
Xuan Sun
BCBenjamin Cao
Benjamin Cao
MNMarina Naval-Sanchez
Marina Naval-Sanchez
TPTony Pham
Tony Pham
YSYu Bo Yang Sun
Yu Bo Yang Sun
SNSusie Nilsson
Susie Nilsson
With age, hematopoietic stem cells (HSC) undergo changes in function, including reduced regenerative potential and loss of quiescence, which is accompanied by a significant expansion of the stem cell pool that can lead to haematological disorders. Elevated metabolic activity has been implicated in driving the HSC ageing phenotype. Here we show that nicotinamide riboside (NR), a form of vitamin B3, restores youthful metabolic capacity by modifying mitochondrial function in multiple ways including reduced expression of nuclear encoded metabolic pathway genes, damping of mitochondrial stress and a decrease in mitochondrial mass and network-size. Metabolic restoration is dependent on continuous NR supplementation and accompanied by a shift of the aged transcriptome towards the young HSC state, more youthful bone marrow cellular composition and an improved regenerative capacity in a transplant setting. Consequently, NR administration could support healthy ageing by re-establishing a more youthful hematopoietic system.

1 June 2018 in Trends in Immunology
Verified
Journal Article
Closed access
MSMelanie R. Shakespear
Melanie R. Shakespear
AIAbishek Iyer
Abishek Iyer
CCCatherine Youting Cheng
Catherine Youting Cheng
KGKaustav Das Gupta
Kaustav Das Gupta
ASAmit Singhal
Amit Singhal
MSMatthew J Sweet
Matthew J Sweet

1 March 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JAJuliana K. Ariffin
Juliana K. Ariffin
KGKaustav das Gupta
Kaustav das Gupta
RKRonan Kapetanovic
Ronan Kapetanovic
AIAbishek Iyer
Abishek Iyer
RRRobert C. Reid
Robert C. Reid
MSMatthew J Sweet
Matthew J Sweet
Broad-spectrum histone deacetylase inhibitors (HDACi) are used clinically as anticancer agents, and more isoform-selective HDACi have been sought to modulate other conditions, including chronic inflammatory diseases. Mouse studies suggest that HDACi downregulate immune responses and may compromise host defense. However, their effects on human macrophage antimicrobial responses are largely unknown. Here, we show that overnight pretreatment of human macrophages with HDACi prior to challenge with Salmonella enterica serovar Typhimurium or Escherichia coli results in significantly reduced intramacrophage bacterial loads, which likely reflect the fact that this treatment regime impairs phagocytosis. In contrast, cotreatment of human macrophages with HDACi at the time of bacterial challenge did not impair phagocytosis; instead, HDACi cotreatment actually promoted clearance of intracellular S . Typhimurium and E. coli . Mechanistically, treatment of human macrophages with HDACi at the time of bacterial infection enhanced mitochondrial reactive oxygen species generation by these cells. The capacity of HDACi to promote the clearance of intracellular bacteria from human macrophages was abrogated when cells were pretreated with MitoTracker Red CMXRos, which perturbs mitochondrial function. The HDAC6-selective inhibitor tubastatin A promoted bacterial clearance from human macrophages, whereas the class I HDAC inhibitor MS-275, which inhibits HDAC1 to -3, had no effect on intracellular bacterial loads. These data are consistent with HDAC6 and/or related HDACs constraining mitochondrial reactive oxygen species production from human macrophages during bacterial challenge. Our findings suggest that, whereas long-term HDACi treatment regimes may potentially compromise host defense, selective HDAC inhibitors may have applications in treating acute bacterial infections.

1 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
GZGuolei Zhao
Guolei Zhao
JLJingwen Lyu
Jingwen Lyu
NVNatalia A. Veniaminova
Natalia A. Veniaminova
RZRobert Zarnowski
Robert Zarnowski
EMEliciane Mattos
Eliciane Mattos
TOTeresa O'Meara
Teresa O'Meara
Candida auris is a fungal pathogen notorious for persistent skin colonization and transmission in healthcare settings. Here, we show that a C. auris conserved adhesin, Als4112, is required for skin colonization via keratinocyte attachment and direct interactions with host extracellular matrix proteins, especially basement membrane proteins such as laminin. Deletion of ALS4112 reduces skin colonization in mouse models of epicutaneous and systemic infection. In addition, coating plastic and catheter surfaces with collagen I or III inhibits C. auris attachment and biofilm formation. Our study highlights the critical role of Als4112 in C. auris colonization and virulence, and explores potential strategies to reduce the pathogen’s adherence to abiotic surfaces and thus its spread in healthcare settings.